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A F LP  - Amplified Fragment Length Polymorphism; a molecular marker generated by a 
combination of restriction digestion and selective PCR  amplification
Chromosome - a cellular structure comprised o f a long, folded D N A  molecule and protein.
D N A  - deoxyribonucleic acid, the substance within cells that carries the "recipe" for the 
organism and is inherited by offspring from parents.
D N A  fingerprinting - cutting the D N A  o f an organism with restriction enzymes, separating the 
pieces by electrophoresis and identifying hypervariable fragments using probes thus generating a 
unique pattern, or "fingerprint" for each species, breed or hybrid. D N A  fingerprints can also be 
generated by amplification of one or more hypervariable D N A  sequences found within the D N A  
o f organisms using PCR  technology followed by electrophoresis o f fragments.
Electrophoresis - a lab technique for determining D N A  fragment sizes by separating them in a 
gel placed in an electric field.
Eukaryotic Cell -  A  cell that contains membrane-bound compartments in which specific 
metabolic activities take place
Gene - a functional unit o f D N A , one "word" in the D N A  recipe.
Genetic code - the information contained in D N A  molecules that scientists describe on the basis 
o f a 4-letter alphabet (A , C, G, and T).
Genetic engineering - the process of transferring D N A  from one organism into another using the 
recombinant-DNA technology that results in a genetic modification; the modified organisms are 
referred to as genetically modified organisms (G M O s) living modified organisms (LM O s) or 
transgenic organisms.
Genetic map - the locations of specific genes along a chromosome marked with probes. 
Genome - the entire D N A  "recipe" for an organism, found in every cell o f that organism.
Km - the Michaelis-Menten constant.
Isozyme - a molecular marker system based on the staining of proteins with identical function, 
but different electrophoretic mobilities.
Mutation - change/s to the D N A  "recipe" o f an organism caused by chemicals, ultraviolet light, 
X-rays, or natural processes.
Glossary
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PCR  - polymerase chain reaction is a method that allows rapid duplication of specific D N A  
molecules in response to temperature changes in a computer-controlled heater.
Plasmid - a small, circular D N A  that is used to transfer genes from one organism into another.
Probe - a very short piece of labeled D N A  used to find a specific sequence of "letters" in a very 
long piece of D N A  from a chromosome or genome.
RAPD -  Randomly Amplified Polymorphic D N A ; a molecular marker based on the differential 
PCR  amplification of a sample of D N A  segments from the genome using short oligonucleotide 
sequences as primers.
Recombinant D N A  (rD N A ) -  D N A  formed by joining pieces of D N A  from two or more 
organisms.
R FLP  - restriction fragment length polymorphism, which describes the patterns o f different 
(polymorphism) sizes o f D N A  (fragment length) that result from cutting with restriction enzymes 
(restriction). See D N A  fingerprinting above.
Sequence - the order o f "letters" in the D N A  "recipe." The D N A  sequence is the chemical 
structure that contains information.
Transformation - a procedure to transfer D N A  into the cells o f an organism. Can be done with 
Agrobacterium (most dicots), physical (freeze-thaw), chemical (bacteria), electroporation (any 
organism), or the particle gun (any organism).
Transgenic - an organism that has been modified by genetic engineering to contain D N A  from an 
external source.
Vm ax - Vm ax is the limiting velocity o f an enzyme as substrate concentrations get very large. 
Vm ax (and V )  are expressed in units o f product formed per time.
Vector - any D N A  molecule capable o f self replication that is used to transfer D N A  into an 
organism; most commonly used are plasmid D N A  vectors or viruses.
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The biotechnology movement in the Caribbean is a fledgling industry that has 
tremendous potential for development. It focuses on the use of fermentation and enzyme 
technologies, tissue culture and recombinant D N A  (rD N A ) technology and is more greatly 
applied to plant varieties rather than animal species. Tissue culture is by far the most developed 
type of technology but increasing attention is being paid to rD N A  technology. There are also 
notable efforts on improved disease diagnostic and genetic resource management services and 
marker-assisted selection for economic traits, including disease resistance. Main areas include 
application in the agriculture sector but the use in medicine, biology and forensics is also being 
promoted.
Greater application of biotechnology in the Caribbean would benefit from the 
development of a regional policy with accompanying legislation and regulations and the 
expansion and improvement o f well-equipped institutions that are adequately staffed. 
Collaboration in development of the biotechnology movement would be enhanced through the 
formation of public-private partnerships in the interest of promoting a unified agenda. Public 
awareness and education, both informally and formally, would indeed enhance the region’ s 
potential for development of a biotechnology industry but this should be complemented with the 
appropriate communication strategies to ensure that information needs would be met.
The biotechnology revolution heralds a new race in which the Caribbean is already 
behind. It is a critical area that must be developed to achieve the region's development goals in a 
sustainable manner and for the region to function in an increasingly competitive global economy. 
Biotechnology development requires a coherent framework, a focused strategic approach, the 
right policies and fiscal environment including tax regime, resource provision structure, 
capacity-building, joint university-private sector projects, venture capital and multidisciplinary 
highly skilled teams. There are several successful models, which can be evaluated and adapted to 
meet the needs of the Caribbean. The biotechnology revolution provides the opportunity to 
develop the region's strengths, conquer its weaknesses and grasp the opportunity presented by 




Contrary to its name, biotechnology is not a single technology. It is, however, a group of 
technologies that share two (common) characteristics, working with living cells and their 
molecules and having a wide range of practice uses that can improve our lives1.
In its purest form, the term "biotechnology" refers to the use of living organisms or their 
products to modify human health and the human environment (Peters 1993) for commercial 
purposes (Betsch 1994). The term brings to mind many different things. Some think of 
developing new types of animals while others anticipate almost unlimited sources of human 
therapeutic drugs. Still others envision the possibility o f growing crops that are more nutritious 
and naturally pest-resistant to feed a rapidly growing world population.
A  narrower and more specific definition of biotechnology is "the commercial application 
of living organisms or their products, which involves the deliberate manipulation of their D N A  
molecules” (Betsch 1994). This definition implies a set o f laboratory techniques developed 
within the last 20 years that have been responsible for the tremendous scientific and commercial 
interest in biotechnology, the founding of many new companies, and the redirection of research 
efforts and financial resources among established companies and universities. These laboratory 
techniques provide scientists with a spectacular vision of the design and function of living 
organisms, and provide technologists in many fields with the tools to implement exciting 
commercial applications.
Biotechnology in one form or another has flourished since prehistoric times. When the 
first human beings realized that they could plant their own crops and breed their own animals, 
they learned to use biotechnology. The discovery that fruit juices fermented into wine or that 
milk could be converted into cheese or yogurt, or that beer could be made by fermenting 
solutions of malt and hops began the study of biotechnology. When the first bakers found that 
they could make soft, spongy bread rather than a firm, thin cracker, they were acting as fledgling 
biotechnologists. The first animal breeders, realizing that different physical traits could be either 
magnified or lost by mating appropriate pairs o f animals, engaged in the manipulations of 
biotechnology.
Throughout human history, a great deal has been learnt about the different organisms that 
our ancestors used so effectively. The marked increase in our understanding of these organisms 
and their cell products gains us the ability to control the many functions of various cells and 
organisms. Using the techniques of gene splicing and recombinant D N A  technology, it is now 
possible to combine the genetic elements o f two or more living cells. Functioning lengths of 
D N A  can be taken from one organism and placed into the cells o f another organism. As a result, 
for example, bacterial cells can be manipulated to produce human molecules. Cows can produce 





According to the University o f California Digital Library the biotechnology movement 
may be traced back to 1652 when Robert Hooke used a microscope to label the walled cavities in 
plant tissue as "cells". In  1830, the Scottish physician, Robert Brown, named the opaque spot in 
plant cells the “ nucleus" and in 1857, biologists first observed small rodlike bodies in dividing 
cells, which, 23 years later, were named chromosomes after being found to absorb certain dyes. 
This was followed in 1869, by the isolation of nuclein from cells o f pus collected in bandages by 
Swiss biologist Fredrich Miescher which was later named deoxyribonucleic acid (D N A ). D N A  
was identified in 1871 in sperm of trout from the Rhine River although its exact role in heredity 
remained unclear. In 1879, the German biochemist Albrecht Kossel found that nucleic acids are 
composed of combinations of the five bases adenine, thymine, cytosine, guanine and uracil. In 
1882 Belgian biologist Eduard Van Beneden discovered that every species has a characteristic 
number o f chromosomes.
The 1900s was an important stage in the biotechnology movement when Gregor Mendel's 
classic experiments in plant genetics and heredity, published 35 years earlier, were rediscovered 
and verified, sparking renewed interest in the field. This was followed in 1902 by the work of 
Walter S. Sutton who studied grasshopper sperm and in so doing, discovered that each 
chromosome pairs with another physically similar one and that they separate during meiotic cell 
division with one member o f each pair going into a different cell. The development o f tissue 
culture techniques in 1902 by an American pathologist was followed, in 1909, by the coining of 
the word “genes” for the still misunderstood elements o f heredity by the Danish botanist, 
Wilhelm Ludwig Johannsen.
In 1919, Thomas Hunt Morgan identified the X Y  male and X X  female chromosomes and 
suggested that some traits may be sex-linked. He later showed how genes can mutate or change. 
Another major beneficial legacy of early twentieth century biotechnology was the discovery by 
Alexander Fleming, in 1928, o f penicillin, an antibiotic derived from the mould Penicillium. 
Large-scale production of penicillin was achieved in the 1940s. However, the revolution in 
understanding the chemical basis o f cell function that stemmed from the post-war emergence of 
molecular biology was still to come. It was this exciting phase of bioscience that led to the recent 
explosive development o f biotechnology.
The invention of the electron microscope in 1930 enabled researchers to see viruses and 
with the advent o f better contrast and staining agents, macromolecules such as D N A  were 
eventually defined. This was complemented by the invention of electrophoresis (use of an 
electric field to move charged particles dispersed in liquid) in 1937 that quickly contributed to 
development o f the disciplines o f immunology, biochemistry, and microbiology.
In 1944, the Rockefeller University researcher, Oswald T. Avery, and colleagues 
demonstrated that D N A  was indeed the carrier o f genetic information and also discovered the 
bacteria that cause bacterial pneumonia. This was followed in 1949, by the discovery o f the 
sequence of D N A  molecules that was found to control cell growth via some sort o f code. During
History of the biotechnology movement
2 http://www.library.ucsf.edu/collres/archives/bio/chron4.html
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this period, and using electrophoresis, Linus Pauling separated normal haemoglobin from sickle 
cell anaemia hemoglobin, proving that genetic disease can be understood in molecular terms.
In 1950, Alfred Hershey and Martha Chase used radioactively labelled Escherisha coli to 
prove that D N A  and not proteins had penetrated the interior of cells and was the true carrier of 
heredity. This was followed in 1951 by the discovery o f Maurice W ilkins and Rosalind Franklin 
who determined the D N A  molecule "outline" using crystallography and X -ray diffraction. It was 
in 1953 that James Watson and Francis Crick proposed a double helix as the molecular structure 
o f D N A , a discovery that later won them the Nobel Prize. Following this and in 1958 American 
researchers, Matthew Meselson and Franklin Stahl, showed that old strands of D N A  act as 
templates for formation of new strands and that synthesis of new D N A  occurs while old 
chromosomes are in the process of uncoiling. During this period, Americans George W. Beadle 
and Edward L . Tatum working with bread mould developed the hypothesis o f "one gene, one 
enzyme."
The 1960s realized significant discoveries in the functioning of genes by the French 
molecular biologists, Francois Jacob and Jacques Monod, who proposed that differences in the 
structure and function of cells result from the selective expression and repression of certain 
genes. This was followed by the cracking of the genetic code by Marshall Nirenburg in 1964.
It was not until the 1970s that the application of biotechnology was realized. This began 
in 1970 with isolation of the first restriction enzyme, a specialized protein used to cut D N A  
strands precisely at specific locations. In 1972, Paul Berg and Stanford colleagues synthesized 
the first recombinant D N A  molecule by linking different D N A  fragments in a test tube and in 
1973, Herbert Boyer and Stanford's Stanley Cohen of the University o f California, San Francisco 
(U C S F ) performed the first genetic engineering experiment by splicing toad genes into E. coli 
bacteria. In 1976, UCSF's J. Michael Bishop and Harold Varmus discovered genes, called 
oncogenes, that can lead to cancer and 13 years later, they shared the Nobel Prize in Medicine 
for that discovery. A t this time, Yuet Wai Kan pioneered molecular techniques that allowed the 
first foetal test to identify sickle cell anaemia, a hereditary blood disease that affects people of 
African origin. In 1977, using rD N A  techniques, K . Itakura and colleagues cloned the first 
human gene which produced the growth inhibiting hormone somatostatin. William  Rutter and 
U C S F  colleagues isolated the gene for rat insulin and transplanted it into bacteria. Five years 
later, genetically engineered human insulin was commercialised.
During this period, the development of rapid DNA-sequencing techniques fuelled the 
growth of scientific inquiry. In 1979, the biotechnology company, Genentech Incorporated, in 
collaboration with U C S F , developed synthetic human growth hormone. Using gene mapping 
techniques, UCSF's Y .W . Kan and Judy Chang discovered the single genetic mutation 
responsible for beta thalassemia, the most common form of life-shortening blood disease. This 
discovery led to prenatal tests for scores o f different regional mutations. John Baxter and 
Howard Goodman were the first to clone the gene for human growth hormone, which became the 
second genetically engineered product to receive government approval.
The 1980s began with cloning of the virus-fighting interferon and was followed in 1981 
by production of the first transgenic mice and transgenic fruit flies. They soon became standard
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ways for studying mutations, gene expression and human disease. Seven years later, a cancer 
prone transgenic mouse became the first patented life form. In 1983, Barbara McClintock won 
the Nobel Prize in Physiology for her discovery that some genes can "jump around" from one 
chromosome to another and in 1987, biochemist William Rutter and his Em eryville Chiron 
Corporation produced the first genetically engineered vaccine against hepatitis b to be put on the 
market.
In 1990, the National Institute o f Health in the United States approved the use of gene 
therapy on a four-year-old girl afflicted with a rare immune system disorder. This era also 
realized the start o f America's Human Genome Project, its goal being to map and clone every 
gene in the human body which was achieved in 2003.
In 1992, Agenda 21, the work programme adopted by the United Nations Conference on 
Environment and Development (U N C E D ) asserted that biotechnology:
“prom ises to make a significant contribution in enabling the development of, fo r  
example, better health care, enhanced fo o d  security through sustainable agricultural 
practices, improved supplies o f  potable water, more efficient industrial development 
processes fo r  transforming raw materials, support fo r  sustainable methods o f  
afforestation and reafforestation and  detoxification o f  hazardous wasters (UN, 1992)”.
The decade following the adoption of these commitments has shown little progress in the 
application of biotechnology in the developing world despite visions of a promising future. 
Instead, the international community has devoted considerable resources to managing 
perceptions of biotechnology risks rather than exploring new opportunities for its use (Pardo et 
al. 2002). It is now more than a decade since world leaders signed Agenda 21. Since then, three 
major developments have occurred. Firstly, the institutions o f globalization that were being 
crafted at the time of the adoption of Agenda 21 are now in place and their influence on the 
international trading system has become a subject o f considerable debate. Secondly, 
biotechnology products have made their debut on the international market and it is now possible 
to assess the performance of biotechnology in the global economy. Thirdly, advances in biology, 
especially molecular biology, signal the prospect o f a new generation of products and services 
that were not conceivable a decade ago (Juma and Konde 2005).
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I. USING BIOTECHNOLOGY TO MODIFY PLANTS AND ANIMALS
This section describes three specific areas of biotechnology namely:
• Industrial biotechnology - fermentation and enzyme technology;
• Tissue culture and plant biotechnology; and
• Molecular biotechnology - recombinant D N A  technology and molecular markers.
A. Industrial biotechnology
1. Fermentation technology
Fermentation technology is the oldest o f all biotechnological processes. It is based on 
fermentation which is a process o f chemical change caused by organisms (table 1) or their 
products, usually producing effervescence and heat. Microbiologists consider fermentation as 
“ any process for the production of a process by means of mass culture of micro-organisms” and 
this is the definition that is widely accepted by biotechnologists.
Table 1: Micro-organisms used in Fermentation Processes
Prokaryotic Unicellular -  bacteria and cyanobacteria 
Multicellular -  cyanobacteria
Eukaryotic Unicellular -  yeast and algae 
Multicellular -  fungi and algae
Fermentation technology began with sweet substances (vegetable or animal) in different 
parts o f the world. The process o f fermentation was probably discovered by observing the 
changes in the juices o f several fruits and other substances that had been kept for a day or more. 
It appears that fermentation technology started simultaneously with settled agriculture during the 
Neolithic period.
2. Enzyme technology
Enzyme technology is best described as the technology associated with the application of 
enzymes as the tools o f industry, agriculture and medicine. Although the earliest reports 
concerning exploitation of enzymes were documented in the late 1800s, true industrial 
application of enzymes only began in earnest in the 1960s. The majority o f enzymes used in 
industrial/biotechnological applications are derived from particular fungi (Aspergillus) and 
bacteria (Bacillus). Safe organisms must be used for consumer-related applications.
Enzymes are proteins and are nature's own biocatalysts. They are produced by living 
systems to accelerate and sustain the myriad of chemical reactions necessary to sustain life with 
more than 3000 enzymes catalyzing a wide array o f reactions being known to exist. The 
disintegration of foodstuffs to amino acids, sugars and lipids is normally accomplished within
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three to six hours depending on the amount and type of food. In the absence of enzymes, 
hydrolysis by digestive enzymes would take more than 30 years.
Enzymes have many advantages over their chemical counterparts in that they are more 
specific and generally possess high catalytic properties. Enzymes can be immobilized, that is, 
enzyme can be linked to an inert support material without loss of activity which facilitates reuse 
and recycling of the enzyme. Enzymes can also be encapsulated or entrapped.
a) Process o f enzyme technology
The identification of a microbial source of an enzyme is necessary to start the process of 
enzyme technology. The properties o f the enzyme must be determined as follows:
• Temperature for optimum productivity;
• Temperature stability profile;
• pH (hydrogen ion concentration) optimum and stability;
• Kinetic constants (Km, Vm ax);
• Whether or not there is substrate or product inhibition;
• Whether or not they have the ability to withstand components of the expected 
feedstock other than substrate.
I f  any of these parameters is unsatisfactory, the screen must continue until improved 
enzymes are located.
Once an enzyme with suitable properties has been located, various decisions must be 
made concerning the acceptability of the organism containing the enzyme to the regulatory 
authorities, the productivity of the organism, and the way in which the enzyme is to be isolated, 
utilised (free or immobilised) and, i f  necessary, purified. I f  the organism is unacceptable from a 
regulatory viewpoint, two options exist: to eliminate that organism altogether and continue the 
screening operation, or to clone the enzyme into an acceptable organism. The latter approach is 
becoming increasingly attractive especially as cloning could also be used to increase the 
productivity of the fermentation process. Cloning may also be attractive when the organism 
originally producing the enzyme is acceptable from the health and safety point of view but 
whose productivity is unacceptable. However, cloning is not yet routine and invariably 
successful so there is still an excellent case to be made for applying conventional mutation and 
isolation techniques for the selection of improved strains.
Screening for new enzymes is expensive so that the intellectual property generated must 
be protected against copying by competitors. This is usually done by patenting the enzyme or its 
production method or, most usefully, the process in which it is to be used. Patenting is initiated 
as soon as there is evidence that an innovative discovery has been made.
Clearly defined media are usually out of the question for large-scale use on cost grounds 
but may be perfectly acceptable when enzymes are to be produced for high value uses, such as 
analysis or medical therapy where very pure preparations are essential. Often the enzyme may be
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purified several hundred-fold but the yield o f the enzyme may be very poor, frequently below 
10% of the activity o f the original material. In contrast, industrial enzymes w ill be purified as 
little as possible, only other enzymes and material likely to interfere with the process which the 
enzyme is to catalyse, w ill be removed. Unnecessary purification w ill be avoided as each 
additional stage is costly in terms of equipment, manpower and loss o f enzyme activity. As a 
result, some commercial enzyme preparations consist essentially o f concentrated fermentation 
broth, plus additives to stabilise the enzyme's activity. The enzymes may then be available for 
sale.
Table 2: List of enzymes by name/class and their traditional applications
Enzyme Application
Proteases Detergents
Chill proofing of beer 
Leather baiting and tendering 
Digestive aids
Clotting and manufacture o f cheese 
Flavor control and production 
Biomedical applications
Cholesterol esterase and oxidase Monitoring serum cholesterol levels
Glucose Isomerase Manufacture of high-fructose syrups as “ high 
sweeteners”
Glucose oxidase Analysis o f blood glucose levels (monitoring serum 
levels in diabetic patients)
Pectinases Juice/Wine clarification 
Coffee bean fermentation
Glucanases Beer making









Novel applications and future uses of enzyme technology w ill include:
(a) The exploitation of enzymes as electrocatalysts (specific biosensors);
(b) Enzymes as analytical tools to measure specific compounds, for the regeneration 
of specific metabolites;
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(c) Enyzme utilization in the synthesis o f bulk organic materials and the production 
of fragrances and cosmetics;
(d) Enzyme utilisation in formation of food flavours and aroma compounds;
(e) The use of enzymes as tools for the detoxification of pesticide residues;
(f) Enzymes as monitors o f toxic chemical levels in food and water.
Biomedical applications of Enzyme Technology w ill include:
(a) The synthesis o f new anti-microbial compounds;
(b) Enzyme replacement therapy;
(c) Enzymes in the treatment o f cancer;
(d) Enzyme graft and dermatological applications;
(e) Enzymes as activators o f precursor biomolecules;
(f) Enzyme technology in the prevention o f dental cavities.
B. Plant biotechnology and tissue culture
Plant biotechnology includes tissue culture/micropropagation as well as the use of 
growth-promoting bacteria to improve plant growth and confer disease resistance. It also 
includes plant breeding using molecular tools.
Tissue culture is a method of biological research in which fragments of tissue from an 
animal or plant are transferred to an artificial environment in which they can continue to survive 
and function. The cultured tissue may consist o f a single cell, a population of cells, or a whole or 
part o f an organ. This is typically facilitated via use of a liquid, semi-solid, or solid growth 
media, such as broth or agar. Tissue culture commonly refers to the culture o f animal cells and 
tissues, while the more specific term plant tissue culture is used for plants. In modern usage, 
"tissue culture" generally refers to the growth of eukaryotic cells in vitro. It is often used 
interchangeably with cell culture to specifically describe the in vitro culturing of sperm donor 
cells. Cells in culture may multiply; change size, form, or function; exhibit specialized activity 
(muscle cells, for example, may contract); or interact with other cells. However, "tissue culture" 
can also be used to refer to the culturing of tissue pieces, i.e. explant culture or whole organs, i.e. 
organ culture. It is a tool for the study of animal cell biology in vitro model o f cell growth to 
allow a highly selective environment which is easily manipulated (used to optimise cell 
signalling pathways).
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Modern plant tissue culture is performed under aseptic conditions under filtered air. 
L iv ing  plant materials from the environment are naturally contaminated on their surfaces (and 
sometimes interiors) with microorganisms, so surface sterilisation of starting materials (explants) 
in chemical solutions (usually alcohol or bleach) is required. Explants are then usually placed on 
the surface of a solid culture medium, but are sometimes placed directly into a liquid medium, 
particularly when cell suspension cultures are desired.
1. The process of tissue culture
Figure 1: Plants placed in a growth medium
Solid and liquid media are generally composed of inorganic salts plus a few organic 
nutrients, vitamins and plant hormones. Solid media are prepared from liquid media with the 
addition of a gelling agent, usually purified agar. The composition of the medium, particularly 
the plant hormones and the nitrogen source (nitrate versus ammonium salts or amino acids) have 
profound effects on the morphology o f the tissues that grow from the initial explant. For 
example, an excess o f auxin w ill often result in a proliferation of roots, while an excess of 
cytokinin may yield shoots. A  balance of both auxin and cytokinin w ill often produce an 
unorganised growth of cells, or callus, but the morphology o f the outgrowth w ill depend on the 
plant species as well as the medium composition. As cultures grow, pieces are typically sliced 
off and transferred to new media (subcultured) to allow for growth or to alter the morphology of 
the culture. The skill and experience of the tissue culturist are important in judging which pieces 
to culture and which to discard.
As shoots emerge from a culture, they may be sliced off and rooted with auxin to produce 
plantlets which, when mature, can be transferred to potting soil for further growth in the 
greenhouse as normal plants. These plants could now be used for extraction of substances of 
interest.
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Figure 2: Plantlets replanted to produce fruit
C. Recombinant DNA technology and molecular markers
1. The structure of DNA
D N A  is the heredity material of a cell that contains all the information needed to recreate 
an organism. A ll D N A  is made up of a base consisting of sugar, phosphate and one nitrogen 
base. There are four nitrogen bases: adenine (A ), thymine (T ), guanine (G ), and cytosine (C). 
The nitrogen bases are found in pairs, with A  & T  and G  & C paired together. The sequence of 
the nitrogen bases can be arranged in an infinite number of ways, and their structure is known as 
the famous "double helix" (Figure 3).
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Figure 3: Molecular structure of DNA
Source: (Matthew Kuure-Kinsey and Beth McCooey 
for Biochemical Engineering Fall 2000)3
The sugar used in D N A  is deoxyribose which is essentially a monosaccharide containing 
five carbon atoms, and including an aldehyde functional group in its linear structure. It is a 
derived from the pentose sugar ribose by the replacement o f the hydroxyl (O H ) at the 2 position 
with hydrogen, leading to the net loss of an oxygen atom (Figure 4).




The four nitrogen bases are the same for all organisms (Figure 5).
Figure 5: The nitrogen-containing organic bases
«— lettrines Guanine (Ci)
I—Pyrimidinei Cytoñiie (Q
The number o f bases and their specific sequence form the basis o f diversity. D N A  does 
not actually make the organism but it makes proteins o f which organisms are composed. The 
D N A  is transcribed into messenger ribonucleic acid (m RN A) and m RNA is translated into 
protein which then forms the organism. The way in which a protein is formed is determined by 
the specific D N A  sequence. This leads to either a different protein, or an inactive protein.
2. Recombinant DNA (rDNA)
Combining D N A , referred to as rD N A , from different existing organisms such as plants, 
animals, insects and bacteria results in modified organisms with a combination of traits from the 
parents. The sharing of D N A  information takes place naturally through sexual reproduction and 
has been exploited in plant and animal breeding programmes for many years.
However, sexual reproduction can occur only between individuals o f the same species. A  
Holstein cow can be mated with a Hereford bull because the two animals are different breeds of 
the same species, cattle. But trying to mate a cow with a horse, a different species o f animal, 
would not be successful.
Since 1972 scientists have been able to identify the specific D N A  genes for many 
desirable traits and transfer only those genes, usually carried on a plasmid or virus, into another 
organism. This process is called genetic engineering and the transfer o f D N A  is accomplished 
using either direct injection or the agrobacterium, electroporation, or particle gun transformation 
techniques. These techniques provide methods of transferring D N A  between any living cells 
(plant, animal, insect, bacterial). V irtually any desirable trait found in nature can, in principle, be 
transferred into any chosen organism. An organism modified by genetic engineering is called 
transgenic.
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In order to form rD N A , the D N A  from both organisms of interest needs to be cut or 
restricted. This is achieved through the use of an enzyme referred to as a restriction endonuclease 
that recognizes a specific sequence of bases on both D N A  molecules such as the following:
5' G G A T C C  3'
3' C C T A G G  5'
The restriction endonuclease Bam H I cuts the same site on each molecule at the position 
indicated by the arrows.
5' G jG A T C C  3'
3' C C T A G ÎG  5'
This results in each cut D N A  molecule having an overhanging piece of single-stranded 
D N A  which are referred to as "sticky ends" because they are able to base pair with any D N A  
molecule containing the complementary sticky end. In this case, both D N A  preparations have 
complementary sticky ends and thus can pair with each other when mixed. The cut sequence 
from each molecule may then be linked by a covalent bond using the enzyme D N A  ligase into a 
molecule o f recombinant D N A  (Figure 3).
a) Process o f forming Recombinant DNA
Figure 6: Example of the process involved in forming recombinant DNA.
Source: http://users.rcn.com/jkimball.ma.ultranet/BiologyPages/R/RecombinantDNA.html
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To  be useful, the recombinant molecule must be replicated many times to provide 
material for analysis. Producing many identical copies o f the same recombinant molecule is 
called cloning. Cloning can be done in vitro, by a process called the polymerase chain reaction 
(PCR) whereby minute amounts of rD N A  are subjected to enzymatic replication in the presence 
of a polymerase enzyme at the desired temperature. It may also be achieved in vivo  using 
unicellular microbes such as Escherichia coli, unicellular eukaryotes such as yeast and in 
mammalian cells grown in cell culture.
In every case, the rD N A  must be taken up by the cell in a form in which it can be 
replicated and expressed. This is achieved by incorporating the D N A  in a host cell. The 
recombinant D N A  is created by placing a D N A  fragment into a vector (plasmid or virus), which 
is then transformed or transfected into bacterial, yeast or mammalian cells. Depending on the 
type of vector used one can either clone or express or modify the inserted D N A  sequence. A  
number of viruses (both bacterial and of mammalian cells) can serve as vectors.
3. Molecular markers
A  molecular marker is any kind of landmark along the D N A  molecules o f organisms. 
Molecular markers are used in molecular biology and biotechnology experiments to identify a 
particular sequence of D N A  along the chromosomes. The three most common types of markers 
used today are:
• Restriction Fragment Length Polymorphism (R FLP);
• Amplified Fragment Length Polymorphism (A FLP );
• Single Nucleotide Polymorphism (SNR);
• Single Sequence Repeat (SSR)
• Randomly Amplified Polymorphic D N A  (R APD ); and
• Isozymes.
O f  the six marker types, the most common molecular markers today are SSR and SNPs 
and to some extent AFLPs.
4. Classification of biotechnology
For ease of reference, several branches of biotechnology have been derived as follows4:
• Red biotechnology is applied to medical processes. Some examples are the 
designing of organisms to produce antibiotics, and the engineering of genetic 
cures through genomic manipulation. For example, since the early 1980s Cuba 
has invested in red biotechnology and has become an important producer of 
biotechnology derived medicines, vaccines and diagnostic kits (C T A  2005). The 
foreign exchange generated through sales of these products is an important 
contribution to the country’ s Gross Domestic Product;
4 http://en.wikipedia.org/wiki/Biotechnology
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Green biotechnology is biotechnology applied to agricultural processes. An 
example would be the selection of plants via micropropagation. Another example 
is the designing of transgenic plants to grow under specific disease pressure 
environmental constraint or in the presence (or absence) of certain agricultural 
chemicals such as herbicides. An example of this is the engineering of a plant to 
express a pesticide, thereby eliminating the need for external application of 
pesticides. An example of this would be the Bt corn. Roundup-ready soybean 
similarly allows the use of the herbicide to clear weeds without affecting the soy 
crop. Whether or not green biotechnology products such as this are ultimately 
more environmentally friendly is a topic o f considerable debate.
White biotechnology, also known as industrial biotechnology, is biotechnology 
applied to industrial processes. A n  example is the designing of an organism to 
produce a useful chemical. Another example is the using of enzymes as industrial 
catalysts to either produce valuable chemicals or destroy hazardous/polluting 
chemicals. White biotechnology tends to consume less in resources than 
traditional processes used to produce industrial goods.
Blue biotechnology is a term that has been used to describe the marine and 
aquatic applications of biotechnology, but its use is relatively rare.
The investments and economic output of all of these types of applied 
biotechnologies form what has been described as the bioeconomy.
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II. APPLICATIONS OF BIOTECHNOLOGY
Advances in biotechnology-related fields such as genomics, genetic engineering, 
chemical engineering and cell technology are transforming the industrial process and 
management landscape. Functional genomics, a relatively new area of research, aims to 
determine patterns o f gene expression and interaction in the genome, based on the knowledge of 
extensive or complete genomic sequence of an organism. It can provide an understanding of how 
microorganisms respond to environmental influences at the genetic level (i.e. by expressing 
specific genes) in different situations or ecologies, and should therefore allow adaptation of 
conditions to improve technological processes. For a range of microorganisms, it is now possible 
to observe the expression of many genes simultaneously, even those with unknown biological 
functions, as they are switched on and o ff during normal development or while an organism 
attempts to cope with pathogens or changing environmental conditions.
A . A g r ic u l t u r a l  b io t e c h n o lo g y
1. D is e a s e  r e s is t a n c e
Genetic engineering is used in the development o f improved plants that are resistant to 
insects, weeds, and plant diseases. For example, an “ insect protection” gene (Bt) has been 
inserted into several crops -  corn, cotton, and potatoes -  to give farmers new tools for integrated 
pest management. Bt corn is resistant to European corn borer. This inherent resistance thus 
reduces pesticide use for controlling European corn borer, and in turn requires less application of 
chemicals and potentially improves yield. Advances in biotechnology are having particularly far- 
reaching impacts on the chemical industry. Micro-organisms, enzymes or their products are 
replacing processes that depended heavily on chemicals, many of which are implicated in 
environmental damage. However, much discussion on biotechnology currently focuses on 
agricultural applications and, to some extent, biomedical uses.
2 . C r o p  im p r o v e m e n t
Although plant science is a relatively modern discipline, its fundamental techniques have 
been applied throughout human history. When early man went through the crucial transition 
from nomadic hunter to settled farmer, cultivated crops became vital for survival. These 
primitive farmers, although ignorant o f the natural principles at work, found that they could 
increase the yield and improve the taste o f crops by selecting seeds from particularly desirable 
plants.
Farmers long ago noted that they could improve each succeeding year's harvest by using 
seed from only the best plants o f the current crop. Plants that, for example, gave the highest 
yield, stayed the healthiest during periods of drought or disease, or were easiest to harvest tended 
to produce future generations with these same characteristics. Through several years o f careful 
seed selection, farmers could maintain and strengthen such desirable traits.
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The possibilities for improving plants expanded as a result o f Gregor Mendel’ s 
investigations in the mid-1860s of hereditary traits in peas. Once the genetic basis o f heredity 
was understood, the benefits o f cross-breeding, or hybridization, became apparent: plants with 
different desirable traits could be used to cultivate a later generation that combined these 
characteristics.
An understanding of the scientific principles behind fermentation and crop improvement 
practices has come only in the last hundred years. But the early, crude techniques, even without 
the benefit o f sophisticated laboratories and automated equipment, were a true practice o f 
biotechnology guiding natural processes to improve man's physical and economic well-being.
More recently, using cross-breeding techniques, transgenic plants are being obtained. 
These plants are more tolerant o f herbicides, resistant to insect or viral pests, or express modified 
versions of fruit or flowers have been grown and tested in outdoor test plots since 1987. The 
genes for these traits have been delivered to the plants from other unrelated plants, bacteria, or 
viruses by genetic engineering techniques. This is but one biotechnological application in crop 
improvement. The process o f plant breeding has been improved through improved 
biotechnological processes that allow the specific identification of heterotic groups, molecular 
approaches to screening, molecular marker assisted selection, embryo rescue, haploid breeding, 
exploitation of somaclonal variation and through site directed mutagenesis or gene silencing 
approaches.
Crop improvement could also be achieved through tissue culture, improved diagnostics 
and other conventional biotechnological approaches such as N-fixation and biopesticides.
B . I n d u s t r ia l  b io t e c h n o lo g y
Industrial biotechnology applies the techniques of modern molecular biology to improve 
the efficiency and reduce the environmental impacts o f industrial processes like textile, paper 
and pulp, and chemical manufacturing. For example, industrial biotechnology companies 
develop biocatalysts, such as enzymes to synthesize chemicals. Using biotechnology, the desired 
enzyme can be manufactured in commercial quantities.
Commodity chemicals such as polymer-grade acrylamide and specialty chemicals can be 
produced using biotechnology applications. Traditional chemical synthesis involves large 
amounts o f energy and often-undesirable products, such as hydrochloric acid (H C l). Using 
biocatalysts, the same chemicals can be produced more economically and more environmentally 
friendly. An example would be the substitution of protease in detergents for other cleaning 
compounds. Detergent proteases, which remove protein impurities, are essential components of 
modern detergents. They are used to break down protein, starch, and fatty acids present on items 
being washed. Protease production results in a biomass that in turn yields a useful byproduct- an 
organic fertilizer. Biotechnology is also used in the textile industry for the finishing of fabrics 
and garments. Biotechnology also produces biotech-derived cotton that is warmer, stronger, has 
improved dye uptake and retention, enhanced absorbency, and wrinkle- and shrink-resistance.
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Some agricultural crops, such as corn, can be used in place of petroleum to produce 
chemicals. The crop’ s sugar can be fermented to acid, which can be then used as an intermediate 
to produce other chemical feedstocks for various products. It has been projected that 30% of the 
w orld’s chemical and fuel needs could be supplied by such renewable resources in the first half 
o f the next century. It has been demonstrated, at test scale, that biopulping reduces the electrical 
energy required for wood pulping process by 30%.
However, the perspectives of, and existing constraints on the development of modern 
industrial biotechnology are located primarily in advanced industrialized nations while the 
performance of Caribbean countries remains marginal (Dembo et al. 1989; Goldstein 1991).
C . E n v ir o n m e n t a l  b io t e c h n o lo g y
Environmental biotechnology is used in waste treatment and pollution prevention and 
applications of this type of biotechnology can more efficiently clean up many wastes than 
conventional methods and greatly reduce our dependence on methods for land-based disposal.
Every organism ingests nutrients to live and produces by-products as a result. Different 
organisms need different types of nutrients. Some bacteria thrive on the chemical components of 
waste products. Environmental engineers use bioremediation, the broadest application of 
environmental biotechnology, in two basic ways. They introduce nutrients to stimulate the 
activity of bacteria already present in the soil at a waste site, or add new bacteria to the soil. The 
bacteria digest the waste at the site and turn it into harmless byproducts. After the bacteria 
consume the waste materials, they die off or return to their normal population levels in the 
environment.
Bioremediation, is an area of increasing interest. Through application of biotechnical 
methods, the development of enzyme bioreactors that w ill pre-treat some industrial waste and 
food waste components and allow their removal through the sewage system rather than through 
solid waste disposal mechanisms has been realised. Waste can also be converted to biofuel to 
run generators. Microbes can be induced to produce enzymes needed to convert plant and 
vegetable materials into building blocks for biodegradable plastics.
In some cases, the byproducts of the pollution-fighting micro-organisms are themselves 
useful. For example, methane can be derived from a form of bacteria that degrades sulfur liquor, 
a waste product o f paper manufacturing. This methane can then be used as a fuel or in other 
industrial processes.
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This section presents some examples o f how biotechnology products may be applied in 
areas such as medicine and forensics.
1. P h a r m a c e u t ic a ls
Many human genes have been cloned in E. coli or in yeast. This has made it possible, for 
the first time, to produce unlimited amounts o f human proteins in vitro. Cultured cells (E. coli, 
yeast, mammalian cells) transformed with a human gene are being used to manufacture more 
than 100 products for human therapy. Human drugs such as insulin for diabetics have been 
produced through cloning of vectors that now carry the chosen gene. Other uses include:
• Production of the human growth hormone (H G H ) for individuals with pituitary 
dwarfism;
• The factor V I I I  for males afflicted with haemophilia A , factor IX  used in 
treatment o f haemophilia B ;
• Erythropoietin (EPO ) for treating anaemia;
• Several types of interferons that play an important role in the first line o f defense 
against viral infections;
• Interleukins that are particularly important in stimulating immune responses, such 
as inflammation;
• Granulocyte-macrophage colony-stimulating factor (G M  -  CSF) for stimulating 
bone marrow after a bone marrow transplant;
• Granulocyte colony -  stimulating factor (G  -  CSF) for stimulating neutrophil 
production, for example, after chemotherapy and for mobilizing hematopoietic 
stem cells from the bone marrow into the blood;
• Tissue plasminogen activator (TP A ) for dissolving blood clots and therefore 
useful for heart attack victims;
• Adenosine deaminase (A D A ) for treating some forms of severe combined 
immunodeficiency (S C ID );
• Parathyroid hormone which is the most important endocrine regulator o f calcium 
and phosphorus concentration in extracellular fluid;
D. Human applications of biotechnology
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• Several monoclonal antibodies that are the most widely used form of cancer 
immunotherapy at this time;
• Hepatitis B surface antigen (HB sA g) used in the preparation of vaccinations 
against the hepatitis B virus;
• C1 inhibitor (C 1 IN H ) that is used to treat hereditary angioneurotic oedema 
(H A N E );
In addition, animal drugs such as the growth hormones, bovine or porcine somatotropin, 
are being produced by the fermentation of transgenic bacteria that have received the appropriate 
human, cow, or pig gene.
2 . M e d ic a l  d ia g n o s t ic  a p p l ic a t io n s
a) Gene therapy
The first clinical gene therapy is underway to correct an enzyme deficiency called
Adenosine Deaminase Deficiency (A D A ) in children. Bone marrow cells are removed, defective 
D N A  in bone marrow cells is supplemented with a copy of normal D N A , and the repaired cells 
are then returned to the patient's body.
b) Diagnosing infectious diseases and genetic disorders
Diagnosis of infectious diseases is a profound application of the new D N A  technology. 
Tuberculosis, A ID S , papillomavirus, and many other infectious diseases, in addition to the 
inherited disorders like cystic fibrosis or sickle cell anemia, are diagnosed within hours by the 
PCR  technique rather than days or weeks by traditional methods. The greatly increased 
sensitivity and speed of the PCR  technique, as compared with traditional methods, allows earlier 
intervention and treatment. PCR  assays w ill soon be available to diagnose diseases of crops and 
livestock.
c) Harnessing microbes for health
In 1897, the German scientist, Buchner made the vital discovery that enzymes extracted 
from yeast are effective in converting sugar into alcohol. Major outbreaks of disease in 
overcrowded industrial cities led eventually to the introduction, in the early years of the present 
century, of large-scale sewage purification systems based on microbial activity. B y  this time it 
had proved possible to generate certain key industrial chemicals such as glycerol, acetone, and 
butanol using bacteria.
Another major beneficial legacy of early twentieth century biotechnology was the 
discovery by Alexander Fleming, in 1928, o f penicillin, an antibiotic derived from the mould 
Penicillium. Large-scale production of penicillin was achieved in the 1940s. However, the 
revolution in understanding the chemical basis of cell function that stemmed from the post-war 
emergence of molecular biology was still to come.
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Since each living creature is unique, each has a unique D N A  recipe. Individuals within 
any given species, breed, or hybrid line can usually be identified by minor differences in their 
D N A  sequences - as few as one difference in a million letters can be detected. Using the 
techniques of D N A  fingerprinting and PCR, scientists can diagnose viral, bacterial, or fungal 
infections, distinguish between closely related individuals, or map the locations of specific genes 
along the vast length of the D N A  molecules in the cells.
D N A  fingerprinting is becoming a common practice in forensics. Similar techniques were 
used recently to identify the bones of the last Czar o f Russia and several members o f his family. 
Immunoassays are used not only in medicine for drug level and pregnancy testing, but also by 
farmers to aid in detection of unsafe levels o f pesticides, herbicides, and toxins on crops and in 
animal products. These assays also provide rapid field tests for industrial chemicals in ground 
water, sediment, and soil.
3 . D N A  f in g e r p r in t in g
a) Identifying organisms
B y using Restriction Fragment Length Polymorphism (R FLP) technology, D N A  
fingerprints can be generated. A ny individual organism can be uniquely identified by its D N A  
fingerprint. Consequently, this fingerprint can be used to determine family relationships in 
paternity litigation, match organ donors with recipients in transplant programs, connect suspects 
with D N A  evidence left at the scene of a crime (in the form of hair or body fluids), or serve as a 
pedigree for seed or livestock breeds.
b) Identifying genes
One important aspect o f genetic engineering projects is to identify the D N A  gene that 
controls a particular trait. In the same way that a visitor might use the state, city, street, and 
house number to locate a friend's house, genetic engineers use genetic "maps" to locate genes. 
The genetic maps are generated by statistical analyses, PCR, RFLP, and D N A  sequencing. Maps 
are being developed for humans, mice, swine, cattle, corn, wheat, and other plants or animals 
with commercial or research importance.
A  current agricultural controversy involves the tomato. A  recent article in the New 
Yorker magazine compared the discovery o f the edible tomato that came about by early 
biotechnology with the new “Flavr-Savr” tomato brought about through modern techniques. In 
the very near future, the opportunity to bite into the Flavr-Savr tomato, the first food created by 
the use of rD N A  technology ever to go on sale would be provided.
d) Forensics
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III. BIOTECHNOLOGY IN THE CARIBBEAN
A  large number of island communities in the developing world lie in rural or semi-urban 
areas where agriculture and aquaculture are the main economic activities. The application of 
biotechnology to these two scientific "cultures" would to a very large extent help revolutionise 
traditional practices into self-sustaining market ventures that could generate badly needed capital 
(DaSilva 1998). Contemporary research in Asia, Latin America and Africa has already led to the 
widespread use of the techniques of tissue culture and genetic engineering in maintaining export 
markets and creating new ones. Current efforts in the Caribbean region are indicative o f this 
growing trend.
The Caribbean nations consist o f more than 25 island States with varying populations that 
depend on a rich diversity o f plant genetic resources for their nutrition, health and well-being. 
The plan "Caribbean Development to the Year 2000: Challenges, Prospects and Policies" 
emphasised the general absence of innovation in Caribbean industry. The acquisition of 
appropriate technology from abroad and the development o f a well-defined infrastructure to 
sustain such technology are identified as effective strategies in responding to these inherent 
weaknesses. Still again, many Caribbean countries with their island economies based on 
terrestrial and marine resources are encouraged to reconcile the sustained and judicious 
development o f these resources with climatic and environmental changes. To meet these 
challenges, and to capitalise on the potential wealth o f their resources, several Caribbean island 
countries have resorted to the systematic application of biotechnology.
One such step has been the establishment of a Caribbean Biotechnology Network, within 
the framework of the United Nations Educational, Scientific and Cultural Organization 
(U N E S C O ) global network of Microbial Resources Centres (M IR C E N s) which resulted from 
political commitment when, a decade ago, the Grenada National Commission for U N E S C O , 
representing the general agreement o f Caribbean ministers responsible for U N E S C O  Affairs and 
the member States in the Caribbean subregion, resolved that "an extension of the international 
network of resources centres be created in the Caribbean region".
Since then, the Caribbean region has maintained a positive attitude towards 
biotechnology. Since 1975, the Caribbean Agricultural and Research Institute (C A R D I) has led 
the region’ s development o f agricultural biotechnology. However, no comprehensive legal or 
regulatory frameworks that address the major issues relevant to biotechnology have been 
implemented in any o f the Caribbean Community (C A R IC O M ) Countries. For the most part, 
existing legal and administrative mechanisms within the Caribbean Region are not adequately 
designed to address modern biotechnology issues such as research and development, trade, 
biosafety, food safety and labelling. However, in 2003, C A R IC O M  Ministers mandated C A R D I 
to develop a regional policy on biosafety and in 2005, the C A R IC O M  Minister with portfolio 
responsibility for Science and Technology provided an Endorsement Statement to support the 
commercialization of biotechnology in the Caribbean region.
In the run-up to the year 2000 and beyond, several island countries, especially in the 
Caribbean region, are confronted by the challenges and threats o f globalisation. In response, 
several island countries are initiating self-reliant strategies aimed at national and regional
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endogenous development. Amongst these strategies, the potential o f biotechnology for economic 
development and technological growth is being tapped.
However, in 2002, Barbados established a National Biosafety/Biotechnology Committee. 
In 2003, the National Biosafety Council was developed in Grenada to assume administrative 
functions in relation to issues outlined in the Cartagena Protocol on Biosafety and Grenada has 
recently developed legal apparatus relevant to genetically modified food imports (Hoffman 
2005).
The Dominican Republic established the Biotechnology and Biodiversity Centre (Centro 
de Biotecnologia y  Biodiversidad -  C IB IO ) in 2000 to serve as the national and scientific base 
for finding biotechnology solutions to the main problems affecting the agriculture, forestry and 
fisheries sectors (Eneas 2005). This Centre serves as the base for exploiting modern 
biotechnologies. Specialized laboratories which focus on tissue culture, molecular biology, 
molecular diagnostics, germplasm management, industrial biotechnology and nutraceuticals have 
been established. Emphasis is also being given to human resource development; a new Masters 
Degree programme has been set-up and protocols have been developed for a wide variety of 
biotechnology products (biopesticides, medicinal extracts, diagnostic methods, scale-up of tissue 
culture protocols).
A t the national level, since the early 1980s and consistently over the last 20 years, Cuba 
has invested in red biotechnology and has become an important producer o f biotechnology- 
derived medicines, vaccines and diagnostic kits. The foreign exchange generated through sales of 
these products is an important contribution to the country’s Gross Domestic Product (GDP). 
Since the 1990s Cuba has placed special emphasis on biotechnology applications to increase 
agricultural productivity and development o f their aquaculture sector (Eneas 2005).
Despite these initiatives and owing to the lack of regulatory frameworks concerning 
modern biotechnology, there are no biotechnology products currently approved for direct 
consumption, processing or for animal feed. Furthermore, there is no information currently 
available for the field testing of biotechnology crops in the area, or the Region’ s policy on co­
existence between biotechnology and non-biotechnology crops. However, research in different 
biotechnologies continues to progress especially at academic institutions and these are presented 
below.
A . I n d u s t r ia l  b io t e c h n o lo g y
1. F e r m e n t a t io n  t e c h n o lo g y
The use of fermentation technology to make industrial products is very much 
underutilized in the Caribbean with Cuba and Puerto Rico making use of this technology 
(Mitchell et al. 2004). To date, the most common application of biotechnology in the Caribbean 
islands has been in the fermentation of rum and beer. In addition, research in the sugar industry 
has focused on the utilisation of products and by products o f the sugar industry for the 
production of value-added products which can decrease foreign exchange expenditure through
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import substitution, as well as increase revenue through non-traditional exports (P. Umaharan5, 
pers. comm.).
A  novel process of the bacterial production from molasses, of xanthum gum, a raw 
material utilized in the pharmaceutical and chemical industries, and which has applications in 
enhanced oil recovery in the petroleum industry, has been developed and patented (Mitchell et al. 
2004).
Biomethanation programmes in the island States o f the Caribbean region have been 
supported by the Caribbean Development Bank (CD B ). Jamaica, with funding from the Latin 
American Energy Organization (O L A D E ) has been particularly active in experimenting with a 
variety o f biodigester designs and models (Clancy and Hulscher 1994).
In Trinidad and Tobago a fermentation process, in which methane from natural gas is 
used as a carbon source for a bacterial culture, found in the natural habitat, can be utilized in an 
industrial production of a highly rich animal protein product. The only other raw materials are 
oxygen, ammonia salts, and a few other minerals. This product is at least nutritionally equivalent 
to high quality fishmeal and furthermore free from dioxin and heavy metals6.
Other applications as articulated by DaSilva and Taylor 1998 include the following:
• Fermentation of sorghum for food and feed;
• Uses of waster yeast from the fermentation industry;
• Identification and characterization of local food pathogens with a view to
increasing regional food safety;
• Production of citric acid from molasses;
• Use of the beneficial fungus, VescicularArbuscular Mycorrhyzae to increase
vegetable and legume crop yield in red kidney beans (Phaseolus vulgaris), 
Winged bean (Psophocarpus tetragonolobus), and moth bean (Vigna aconitifolia);
• Development of legume inoculant;
• Recycling agricultural wastes for the production of animal feed and organic 
fertilizer;
• Use of microbes in animal feed as a substitute for antibiotics.




In  the Caribbean, work with immobilized Protein A  or Protein G  revealed that the yield 
o f antibodies purified using affinity chromatography was increased by 500% by including 
kosmotropic salts in the binding buffer. This is due to the inclusion of strongly hydrated anions 
(citrate, sulphate and phosphate) and weakly hydrated cations such as ammonium and potassium 
(Ngo and Narinesingh 2008).
Several other studies that have investigated the properties and activities o f enzymes have 
been conducted (W u et al. 1999, Mankasingh et al. 2000, Brahim et al. 2001, Brahim et al. 2002, 
Ngo et al. 2005).
B . P la n t  b io t e c h n o lo g y  a n d  t i s s u e  c u lt u r e
Most o f the tissue culture work on all crops was initiated at U W I in the early 1980s at its 
St. Augustine campus. Protocols for a number of tropical crops including banana, plantain, 
pineapple, aloe, breadfruit, jackfruit, sweetpotato, cocoa, anthuriums, tropical orchids, carambola 
were developed. An in vitro breeding method for fusarium resistance in banana as well as an in 
vitro hardening method for banana was developed. Protocols for developing yam varieties free 
of brown spot virus was developed in C A R D I headquarters in Trinidad and Tobago. They 
worked on germplasm storage as well as commercial micropropagation of anthurium.
More recently, tissue culture has been used as an economical tool for the 
micropropagation of many food and ornamental plants (Table 3).
2. Enzyme technology
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T a b le  3 . E x a m p le s  o f  m o r e  r e c e n t  a p p l ic a t io n  o f  t i s s u e  c u lt u r e  
_________________to  t h e  a g r ic u l t u r a l  s e c t o r ______________________
C o u n t r y A p p l ic a t io n
Bahamas The Ministry of Agriculture supports the bulk production of citrus fruits and root 
crops as well as conservation and production of native orchids and floristic 
ornamentals.
Barbados Since 1979, the White Lisbon cultivar of the yam species, Discorea alata has 
been improved through elimination of the viral disease, internal brown spot. 
Distribution of plantlets of the improved variety has led to 40% increase in crop 
yield;
Development of a resistant strains of hot pepper and tomato to bacterial spot 
disease caused by Xanthomonas campestris var. vesicatoria.
Dominica Leaf burning disease caused by the fungus, Pythium myriotylum in cocoyam 
(tannia) has been eliminated through biocontrol systems.
Grenada The spread of Moko disease caused by Pseudomonas solanacearium in bananas 
has been controlled.
Guyana National Agricultural Research Institute (NARI) and FA O  are engaged in the 
production of shoots from dormant axillary buds of pineapple (Ananas comosus 
L. Marr.).
Jamaica Development of virus-free planting material for the Irish potato, Solanum 
tuberosum
Production of yam plantlets of the variety Dioscorea cayensis, D. rotunda, D. 
alata and D. Trifida;
Development of the mushroom industry using oyster mushrooms, Pleurotus 
sajor-caju;
Development of strains of the hot pepper (Capsicum chinense) that are resistant 
to potyviruses;
Tissue protocols for the following have been developed:
- sweet potato -  Ipomoea batatas
- cassava -  Manihot esculenta
- dasheen -  Colocasia esculenta
- plaintains -  Musa spp.
- breadfruit -  Artocarpus altilis
- jackfruit -  A. heterophyllus
- carambola -  Avevrhoa carambola
- yam bean -  Pachyrhizus erosus
- cacao -  Theobroma cacao
- pineapple -  Ananas comosus
- sugar cane -  Saccharum officinarum
St. Kitts & Nevis Production of tuber crops
St. Vincent & the 
Grenadines
Yam tissue cultures introduced by the Chinese
Trinidad & 
Tobago
UW I developing protocols and appropriate biocontrol and quarantine measures 
targeted at improving yields of yams, sweet potatoes, cassava and plaintain 
species.
CARDI Repository for virus-free yam material and germplasm storage of selected crop 
species of economic significance.
Sources: DaSilva and Taylor 1998; Hoffman 2005; Lawrence et al. 2005.
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Another recent development is research into methods for food preservation and extension 
of the shelf-life o f plant products. The Mona and St. Augustine campuses of U W I are involved 
in joint ventures in tissue culture applications. Also, the Jamaican Government collaborates with 
industry in the production of white potatoes, ginger, banana, and yam. In Trinidad, gingerlilies, 
roses and orchids are produced for local markets. Recently, the technique of embryo transfer has 
being used to boost meat and milk production (DaSilva and Taylor 1998).
Specifically, at the Mona Campus, extracts from a number o f plants have been identified 
as having potential in the field o f medicine (Table 4).
T a b le  4: E x a m p le s  o f  t h e  p o t e n t ia l  o f  p la n t  e x t r a c t s  in  m e d ic in e
Plant Usage
Unripe tamarind Antibacterial activity
Leaf-of-life leaves (Bryophyllum 
pinnatum)
Antibacterial activity
Spirit weed (Eryngium foetidium) Anti-convulsion properties
Breadfruit (Artocarpus altilis) Anti-flammatory potential
Freeze-dried noni (Morinda citrifolia) Anti-flammatory potential
Abutilon trisulcatum (choline-rich plant) Treatment o f memory disorders
Ginger (Zingiber officinale) Treatment o f rhematoid arthritis
Neem Disinfectant potential
Microbes in animal feed Antibiotics
Guinea hen weed Bioactive anti-cancer chemical
Turmeric (Curcuma longa) Anti-inflammatory
Aloe (Aloe vera) enhances immune function
Sarsaparilla (Smilax regelii) Prevents or relieves rheumatism
Source: Mitchell et al. 2008; Bone 2003.
C . R e c o m b in a n t  D N A  t e c h n o lo g y  a n d  m o le c u la r  m a r k e r s
1. R e c o m b in a n t  D N A
Recombinant D N A  technology is being successfully used in development o f the 
anthurium industry. This is a commercial venture that is being undertaken at U W I, St. Augustine 
and seeks to broaden the range of colours o f the indigenous anthurium, Anthurium andraeanum, 
through the introduction of genes that code for new colours from other species (Elibox and 
Umaharan 2008). It is expected that these unique colour schemes would greatly enhance the 
marketability for the species.
W ithin the same species, research into the development of resistant varieties using a 
bioengineered strain o f Xanthomonas axonopodis pv dieffenbachiae has resulted in the first 
bacterial blight resistant varieties o f Anthurium andraeanum Hort., which are presently being 
commercially exploited. Further research on this species is addressing the development of 
nematode-resistant varieties (E libox and Umaharan 2007).
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A t the Mona Campus of U W I, research has been conducted into developing varieties of 
papaya resistant to ring spot disease using transfer o f resistant genes that have been obtained 
from local varieties (P. Tennant7, pers. comm.). Results have indicated that 40 - 50 %  of these 
transgenic plants are free of the virus and research using rD N A  techniques to ensure 100 % 
success continues (Cai et al. 1999). Research using rD N A  techniques is also being conducted 
into producing virus-resistant varieties o f the sweet orange and gragefruit.
2 . M o le c u la r  m a r k e r s
a) Molecular markers in genetic resource management
Molecular markers, namely RFLPs and RAPDs have been used to determine the stock 
structure o f the four-wing flyingfish, Hirundichthys affinis, in the central western Atlantic 
(Gomes et al. 1998, 1999). This research confirmed that the Caribbean stock (inclusive of the 
Netherlands Antilles and Aruba) is indeed genetically separate from the South American stock 
and, as such, should be managed separately.
Microsatellite markers were used to determine the Barbados Blackbelly population 
structure through the of microsatellite loci to include or exclude individuals as belonging to this 
population. Polymerase chain reaction genotype analysis using dinucleotide microsatellite 
markers were used to examine the genetic diversity present in the Barbados population as 
compared with populations of West African origin, V irg in  Island White and Blackbelly from the 
United States. Results suggested that the observed heterozygosity prevailing in the Barbados 
Blackbelly and populations from the United States were genotypically different (Roberts and 
Thomas 2003).
Molecular fingerprinting of all cocoa genetic resources available at the International 
Cocoa Genebank in Trinidad using multiplex SSR markers has allowed the identification of 
mislabeled accession. The information has also been used to develop a core collection 
representing the cocoa genepool and having desirable characteristics.
i. Molecular markers in crop improvement
Molecular markers have been used to identify heterotic groups within hotpepper 
(Capsicum chinense Jacq.) (Moses and Umaharan, 2008). This information is being used in 
heterosis breeding to improve the yield in hotpepper (Umaharan, P. pers. Comm.).
Molecular markers based on A FLP  have been used to identify markers for sugar and fibre 
content in Sugarcane, which can be used to improve yield. Similarly, SSR markers associated 
with disease resistance, butterfat content and other agronomically important traits in cocoa 
(Theobroma cacao) is being developed using a Refractario population using association 
mapping. Such markers w ill have widespread usage beyond individual crosses. Molecular 
markers linked to bacterial blight resistance in anthurium are also being pursued in collaboration 
with researchers in Hawaii.
7 Dr. P. Tennant, Lecturer, Medicinal Plant research Group, Biotechnology Centre, University of the West Indies, Mona, Jamaica.
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ii. Molecular markers in diagnostics
There are numerous begomoviruses that affect tomato production in the Caribbean. 
W ork is ongoing at the Mona and St. Augustine campuses of U W I as well as in Cuba and 
Guadeloupe. In a European Union-funded regional project, viz., B E T O C A R IB  involving Cuba 
(Domican Republic (IS A ), Trinidad and Tobago (U W I), France (IN R A , C IR A D ) and the United 
Kingdom (N R I), molecular markers were developed to characterize the various begomoviruses 
and strains affecting tomato within the Caribbean region. Tomato varieties were identified with 
resistant to these viruses for deployment. Similarly Phytophthora palmivora and Crinipellis 
perniciosa strains were characterized to determine relationship with aggressiveness.
There is ongoing work on characterizing the bacterial w ilt strains in the family 
Solonaceae and Musaceae (Ralstonia solanacearum) throughout the Caribbean (U W I, St. 
Augustine; C IR A D , Guadeloupe), pepper viruses, coconut diseases (U W I, Mona; Coconut 
Research, Jamaica), Citrus tristeza virus in citrus and bacterial and fungal diseases in a number 
o f vegetables including cabbage and pumpkin. The improved precision with which pathogens 
can be diagnosed is allowing appropriate deployment o f resistance; appropriate quarantine 
measures to be developed by the Council for Trade and Economic Development (C O T E D ) and 
providing a tool for epidemiological studies aimed at integrated pest management.
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IV. CONCLUSIONS AND RECOMMENDATIONS
The biotechnology movement in the Caribbean is a fledgling industry that has 
tremendous potential for development and this would be facilitated through the development of 
policies complete with the required legislation and regulations to support them. A  coherent 
regional biotechnology policy, within a broader science, technology and innovation policy is 
critical for creating an enabling environment that can foster biotechnology development. 
However, no regional policy exists and since each country has the responsibility for policies and 
regulations in their own islands, the situation posed by the geographical and political 
fragmentation of the Caribbean Region poses a great challenge for development of such a policy. 
Notwithstanding the challenge, a regional policy is desirable towards not only providing a vision 
and identify priority areas for development but also to encourage a culture o f innovation through 
funding mechanisms that would promote collaboration in research and industry development in 
the identified priority areas. Such a policy should also provide fiscal incentives for funding 
research/ technology development initiatives as well as mechanisms to promote technology 
transfer and foreign direct investments. In addition, they should support enabling systems 
dealing with intellectual property rights, biosafety and rewards.
Recognising the importance of a regional policy C A R IC O M  has established a working 
group with a mandate to develop a Caribbean Biotechnology and Biosafety Policy. In the 
absence of a regional policy, Barbados and Jamaica have developed national biotechnology 
policies and Trinidad and Tobago is in the process o f developing a draft policy (P. Umaharan8 
pers. comm.) having already developed some enabling policies and legislation on intellectual 
properties (Mitchell et al. 2004). In the Greater Caribbean, Cuba and the Dominican Republic 
also have well developed biotechnology and biosafety policies.
A t the regional level, the Inter-American Institute for Co-operation on Agriculture ( IIC A ) 
has developed a biotechnology strategy document entitled ’’Caribbean Programme on 
Biotechnology and Biosafety” , which includes four strategic elements including research and 
development, information management, capacity building and commercialisation of biotech 
products. The Caribbean programme for biotechnology and biosafety dovetails into a 
hemispheric programme on biotechnology and biosafety developed by IIC A . It is recommended 
that the region take the initiative to develop such a policy and to ensure the institutionalisation of 
the appropriate supporting agencies and furnishing with necessary human resource and technical 
capacity.
The development of a regional policy and the successes gained by countries that have 
invested in science and technology and, more specifically, biotechnology are largely attributed, 
first and foremost to visionary leadership and strong political commitment. Such commitment 
would be manifested in the development o f appropriate policies in a participatory manner that 
would guide development and commercialization of the industry.
The development o f key partnerships among public research (universities, national 
research institutions and centres o f excellence), the private sector (industry) and the government
8 Professor Pathmanathan Umaharan, Professor o f  Biotechnology, University o f  the W est Indies, St. Augustine Campus, St. Augustine, Trinidad
and Tobago.
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are necessary in order to promote the biotechnology agenda. Public and private investment in 
science and technology infrastructure and biotechnology programmes would promote research in 
biotechnology resulting in the production of useful products which could then be 
commercialised. However, there is a disconnect between research and the industrial activities of 
the private sector. Many national institutions that were created to serve as the link between the 
University and the industry have largely failed (P. Umaharan pers. comm9.). The new 
developmental paradigm requires that the university work alongside the private sector in 
industrial parks so that there is a close direct link between research and enterprise development. 
However, such ventures would require venture capital. It is recommended that the appropriate 
environment should be created for the private sector and venture capitalists to become critical 
partners in biotechnology efforts o f the country.
In this regard, organizations such as the National Commission on Science and 
Technology (N C S T ) in Jamaica could have a primary role to play, because it is a body that can 
facilitate linkages, bridge the existing gaps and ensure best results. The Commission’ s National 
Biotechnology Coordination Committee is well positioned to play a critical role in monitoring, 
coordinating and providing advice for biotechnology development at a national level. 
Governments are also well poised to establish commonly agreed biotechnology research and 
development targets among key organizations in agreed priority areas. In this regard, research at 
the university level w ill be linked to industry needs and special efforts w ill be given to linking 
science faculties and their centres to businesses locally and overseas. Governments could also 
support and encourage the transfer of the technology ensuring that research results are moved to 
commercialization. In order to further promote the development of the biotechnology/industry 
interphase, scientists should be offered special training courses in business and marketing to 
augment a business/entrepreneurial culture10.
Given the current global food crisis the promotion of agricultural research that includes a 
higher biotechnology component is recommended. In this regard, governments could encourage 
the establishment and development of Centres of Excellence in biotechnology and bio­
engineering. Also, the introduction of formal/university training programmes in biotechnology 
can also assist in the development of capacity. This would provide the necessary enabling 
environment for research and development in biotechnology and allied fields and could be 
promoted through the development o f infrastructure, incentives and regulatory frameworks. 
Priority should be given to agro-biotechnological research, particularly to increasing agricultural 
productivity and food security in the region. To  date, more than half o f the Caribbean islands are 
using biotechnology in agricultural production but there is little commercialization of the 
products except for tissue culture and the micropropagation of plants. The biotechnology centres 
and research programmes that are located in Barbados, Grenada, Jamaica and Trinidad and the 
researchers are anxious to promote research and generate positive biotechnology policy 
initiatives.
9
Professor Pathmanathan Umaharan, Professor of Biotechnology, University of the West Indies, St. Augustine Campus, St. Augustine, Trinidad 
and Tobago
10 Biotechnology for Socio-Economic Development: A Policy for Jamaica. National Commission on Science and Technology, Draft 5. 
September 2006.
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Further to this it is recommended that support and encouragement for the formation of 
clusters o f high value-added manufacturers in the supply chain should be provided11. As such, 
biotechnology should result in increasing productivity and improving quality to meet market 
needs. The promotion of entrepreneurship and provision of rewards for innovators would 
support investment in biotechnology approaches.
The creation of an enabling environment for science, technology and innovation and 
more specifically for biotechnology to thrive is considered necessary. This would include 
laboratory structures complete with relevant facilities for diagnostic applications. O f  importance 
here is the establishment o f a commercial tissue culture facility that would allow the marketing 
of plantlets to farmers (S. M itchell12, pers. comm.). This is already in existence in Jamaica in the 
Manchester area where the Christiana Potato Growers Association has set up a facility that has 
resulted in the production of sweet and irish potato and ginger plantlets (M . B lair13, pers. 
comm.). These facilities should be equipped with an efficient internet system, complete with 
state o f the art computers to facilitate ease of communication and instructional activities.
The appropriate technical expertise to operate these facilities would be needed 
(N IH ER S T/C C S T 2004). The lack of a critical mass of scientists in academic and research 
institutions has been identified as a constraint to biotechnology development. This can be 
overcome by capacity-building and by enhancing collaboration among players within the region. 
The universities in the region should aim at recruiting graduates from a broad disciplinary base 
(biologists, chemists, information technologists, social scientists, agriculturists, engineers, 
medical scientists and clinicians) into postgraduate programmes that provide a flexible training 
environment that w ill provide the requisite grounding in a specific area and the team skills to 
function in a multi-disciplinary unit that can support biotechnology industry development (P. 
Umaharan14, pers. comm.).
Although many efforts were made in the past, these efforts could not be sustained. The 
only successful collaborations have been through the implementation of joint regional research 
projects, which helped to build trust among partners and led to other successful projects. The 
regional efforts should therefore focus on establishing competitive funding mechanisms with the 
goal o f bringing Caribbean biotechnologists together to achieve regional development goals. 
Teams established through such mechanisms w ill develop a level o f expertise, coherence and 
impetus that should enable them to attract independent funding. A  consultative group of 
Caribbean biotechnologists can form the basis o f developing the regional agenda15.
Development and implementation of a public education strategy addressing the key 
elements o f biotechnology, and focusing in general on methodologies and more specifically on 
opportunities and risks would assist in creating appropriate attitudes to the technology and 
promoting support for it. Such a strategy could be included in the curriculum of the Caribbean
11 Biotechnology for Socio-Economic Development: A Policy for Jamaica. National Commission on Science and Technology, Draft 5. 
September 2006
12 Dr. Sylvia Mitchell, Lecturer, Medicinal Plant research Group, Biotechnology Centre, University of the West Indies, Mona, Jamaica.
13 Dr. Marcia Blair, Technical Officer, National Commission on Science and Technology, 1 Devon Road, Kingston 10, Jamaica.
14 Professor Pathmanathan Umaharan, Professor of Biotechnology, University of the West Indies, St. Augustine Campus, St. Augustine, Trinidad 
and Tobago
15 Professor Pathmanathan Umaharan, Professor of Biotechnology, University of the West Indies, St. Augustine Campus, St. Augustine, Trinidad 
and Tobago
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Examinations Council (CXC)and adapted to meet the needs of young people o f primary school 
age. In conjunction with this strategy would be the development o f an efficient electronic system 
where information on biotechnology would be available and easily accessible.
Public education should be pursued in conjunction with a public awareness strategy 
which should result in acceptance of the value and potential o f biotechnology applications. 
Ongoing public education and awareness campaigns as well as participatory systems of 
development are required to ensure that there is no discord between the development goals o f the 
region and the public interest. Particular emphasis w ill be placed on internships, beginning at the 
secondary school level, for teachers and students. Also, in an effort to develop national capability 
in biotechnology, at the highest international standard, a specific programme could be 
implemented to provide training of top students identified at the tertiary level, through the award 
of scholarships and fellowships to support training at reputable overseas institutions.
In terms of the research agenda, more specific recommendations would include the 
following:
• Development o f Biological Control and Pest Management Strategies. This would 
encompass the conduct o f specialized research towards the development and 
production of biocontrol agents for pest management to significantly reduce the 
use of chemicals;
Biopesticides and genetic approaches also provide a more environment friendly 
approach to managing pest and disease problems. Cuba is the forerunner in 
biopesticides research and development and the Caribbean region could use this 
model in developing a range of products that can be marketed throughout the 
Region. There is a growing impetus in the region for developing genetic 
resistance to biotic stresses in the region, in many islands. A  co-operative 
approach can considerably strengthen this effort supported by molecular tools to 
develop it into an industry to supply the region with tropically adapted 
germplasm. Patenting the tools developed can provide global leverage and 
economic returns;
Pests and disease problems in the agricultural sector are of tremendous concern as 
the movement of pests and the spread of diseases among the islands of the 
Caribbean increases the need for effective quarantine measures16. In this regard, 
biotechnology provides tools to diagnose diseases rapidly and monitor their 
evolution and spread. These tools can greatly assist quarantine systems in the 
region which are already operating at full capacity;
The medical branch of biotechnology extends beyond the genomic principles and 
is closely related to physics and mathematics through the development of 
diagnostic equipment. As such it would be important to provide support for the
16 Professor Pathmanathan Umaharan, Professor o f  Biotechnology, University o f the W est Indies, St. Augustine Campus, St. Augustine, Trinidad
and Tobago
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development of sub-surface systems that have multiple uses in medicine and 
petrochemical excavation;
• Research into the promotion of athlete-enhancing potential models through 
biotech advancements within the context of the limitations to human performance, 
could provide an advantage. Some of these include legal metabolic enhancers 
possibly herbal sources and athletic wear17.
• Development of telecommunication systems would greatly enhance the delivery
of healthcare services such as Telemedicine;
• The conservation of genetic resources becomes even more urgent in small island
States, where alternate use of land is leading to rapid genetic erosion. In this 
regard, biotechnology can provide novel tools such as microchip arrays that can 
be used to rapidly screen for genes and proteins, and methods to isolate and 
engineer genes and mass produce novel products in bioreactors 18. It also
provides tools for genetic resource monitoring and sustainable use and
development o f efficient strategies for the in situ conservation of bioresources. 
Focus should therefore be on exploiting the enormous marine and land
biodiversity as well as the indigenous knowledge available in the region;
• It is important to also develop strategic partnerships with global leaders in each
area to commercialize the products from these bioresources, so that
pharmaceuticals, neutraceuticals and other industrial products can be developed 
and countries can benefit;
• In order to maximize the application of products that have been successfully
developed, the ability to store, manipulate, manage and decipher information from 
very large genome-based or protein-based data sets or molecular marker data 
(bioinformatics) is imperative to the functioning of a biotechnology enterprise. In 
this regard, it would be useful to obtain the necessary equipment and expertise to 
ensure that this information is secure and could be sorted.
Protection o f Intellectual Property Rights (IPRs). Governments are well positioned to 
play a proactive role in creating awareness of the importance of IPRs in biotechnology research 
and innovation through the development of databases and assistance to scientists and 
entrepreneurs through the establishment o f appropriate IPR Offices. In Jamaica, such an office 
has been established and in Trinidad and Tobago a committee to oversee the protection of IPRs 
has recently been established. However it is recommended that harmonization of IPR  legislation 
to include issues related to access and benefit sharing given the various treaties and agreements 
that Caribbean countries have signed and/or ratified (the W orld Trade Organization/Trade- 
related aspects of Intellectual Property Rights (W TO/TRIPS) Agreement, Convention on
17 Professor, Peter Corridon, Professor, University of Trinidad and Tobago, O ’Meara Campus, Trinidad and Tobago.
Professor Pathmanathan Umaharan, Professor o f  Biotechnology, University o f the W est Indies, St. Augustine Campus, St. Augustine, Trinidad
and Tobago
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Biological Diversity and its Cartagena Protocol and the International Treaty on Plant Genetic 
Resources) should be pursued (C T A  2005).
The technological gap between the developed and developing world has been identified 
as the single most important constraint to biotechnology development in the developing countries 
and it is continuing to widen, as new biotechnologies are developed at a rapid rate. The United 
Nations Industrial Development Organization (U N ID O ), recognizing the weakness of developing 
countries in this area, established two international centres (Trieste, Italy; New  Delhi, India) for 
genetic engineering and biotechnology with the objective o f transferring technologies to member 
countries. These should be fully utilized in the Region. In addition, many biodiversity-rich 
developing countries have established bilateral collaborative programmes with technology-rich 
developed countries to allow access to biodiversity in exchange for technology. Others have 
established collaborative agreements with institutes in the United States where local researchers 
work with their counterparts, towards developing local products and processes, which w ill 
benefit the local economy. Each country needs to define an appropriate strategy which also takes 
into account (IPR) issues to overcome this hurdle o f the ever-expanding technology gap 
(Umaharan 2005).
The development o f marketing strategies for commercial use of developed crop varieties 
would greatly enhance distribution and help to bring economic returns. In this regard, 
indigenous crop genetic diversity should be systematically exploited for developing novel 
ornamental, medicinal or other crop varieties for commercial purposes. Such initiatives may 
result in the development o f niche agricultural industries in the region. For example, ornamental 
crops which require high capital inputs and intensive production systems are ideally suited for 
the small farm holdings in the Caribbean. Linkage of the ornamental plant industry to the 
dynamic tourism sector in the Caribbean together with the geographical proximity o f the 
Caribbean region to the vast North American market could well provide opportunities for market 
expansion. Biotechnology also has the potential for providing opportunities for developing 
specialty foods based on indigenous crops (Umaharan 2005).
The role o f government in the development of biotechnology is to induce the creation of 
national innovation systems, which can provide the resources and capabilities needed to master 
and develop the technologies involved, with particular emphasis on their engineering, 
technological and commercial aspects. Such scientific capabilities are the basis for later 
industrial applications. Agricultural biotechnology has developed in a limited and uneven way in 
the Caribbean. The advances that have occurred are the results o f individual actions taken by 
scientists, research managers and companies. Governments have frequently supported or 
complemented the initiatives o f scientists and research institutes to create or strengthen scientific 
capabilities through special biotechnology development programmes. Changes in intellectual 
property protection, expanding it to include biological materials and living beings, are too recent 
to have had an effect on biotechnology. The relatively more advanced countries in the region are 
ready to implement programmes targeted on specific industries.
In this regard and given the cross-cutting and interdisciplinary nature o f biotechnology as 
well as the policy and trade-related issues, it would be necessary to coordinate the activities of 
key ministries such as environment, agriculture, health, industry, planning, finance, trade,
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education and foreign affairs, administrations, industries, legal bodies and research institutions 
(C T A  2005).
However, it is posited that in the face of growing privatization of the biotechnology 
industry, the industry would never be a primary source in the developing world (Schatzmayr and 
Bernades 1994). The onus is therefore on governments to develop the appropriate policies to 
promote the application of biotechnology to industry thereby providing competition to the 
private sector in promoting a viable biotechnology opportunity in the Caribbean. Along with 
this, a cooperative approach can consistently strengthen this effort supported by molecular tools 
to develop it into an industry to supply the Caribbean region with tropically adapted germplasm. 
To  date, only Cuba has had a national strategy of creating a biotechnology-based industry, as 
part of its ambitious export plans. Patenting the tools developed can provide global leverage and 
economic returns.
The biotechnology revolution heralds a new race in which the Caribbean is already 
behind. It is a critical area that must be developed to achieve the region's development goals in a 
sustainable manner and for the region to function in an increasingly competitive global economy. 
Biotechnology development requires a coherent framework, a focused strategic approach, the 
appropriate policies and fiscal environment including tax regime, resource provision structure, 
capacity building, joint university-private sector projects, venture capital and multi-disciplinary 
highly skilled teams. There are several successful models, which can be evaluated and adapted to 
meet the needs of the Caribbean. The biotechnology revolution provides the opportunity to 
develop the region's strengths, conquer its weaknesses and grasp the opportunity presented by 
the greatest challenge yet to confront mankind.
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